The Journal of Organic Chemistry
Article
(
E)-5-(2-(5-Bromofuran-2-yl)vinyl)-1-phenyl-3-(p-tolyl)-1H-pyra-
Calcd for C H N OSi: C, 70.09; H, 6.54; Si, 9.11. Found: C, 69.82;
18 20 2
H, 6.59; Si, 9.02.
zole (4r). Light yellow needles; yield 316 mg (78%); mp 109−110 °C
1
(
EtOH−Me CO−H O); H NMR (400 MHz, DMSO-d ): δ 7.77 (d,
General Procedure for the Preparation of 5-Phenyl-1-
hetarylpent-1-en-4-yn-3-ones Phenylhydrazones 6a−f. Phe-
nylhydrazine 2a (119 mg, 1.1 mmol, 1.1 equiv) and AcOH (0.4 mL)
were added successively to a solution of enynone 1a, b, e, f, h, i (1
mmol, 1.0 equiv) in 3.5 mL of EtOH. The solution was refluxed
(water bath) with stirring (the duration of reflux for each example is
indicated in the Table 4) and cooled; the precipitated crystals were
filtered off. The product was dried in vacuo (40 mmHg) for 1 h.
1-((E)-1-(Furan-2-yl)-5-phenylpent-1-en-4-yn-3-ylidene)-2-phe-
nylhydrazine (6a). Orange needles; yield 234 mg (76%); mp 108−
2
2
6
J = 8.2 Hz, 2H), 7.64−7.60 (m, 2H), 7.58−7.51 (m, 3H), 7.33 (s,
1
(
1
1
H), 7.26 (d, J = 8.0 Hz, 2H), 7.13 (d, J = 16.2 Hz, 1H), 6.68−6.64
1
3
1
m, 3H), 2.34 (s, 3H); C{ H} NMR (101 MHz, DMSO-d ): δ
6
54.4, 151.6, 142.1, 139.4, 137.9, 130.3, 130.0, 129.8, 128.8, 125.9,
25.7, 122.9, 119.3, 114.8, 113.7, 113.6, 101.7, 21.3; IR (CHCl ,
3
−
1
cm ) ν 1599, 1501, 1481; Anal. Calcd for C H BrN O: C, 65.20;
2
2
17
2
H, 4.23; Br, 19.72. Found: C, 65.16; H, 4.54; Br, 19.34; HRMS (ESI)
m/z calcd for C H BrN O [M + H] 406.0596, found 406.0619.
+
22
18
2
(
E)-3-(5-Bromofuran-2-yl)-5-(2-(5-bromofuran-2-yl)vinyl)-1-phe-
1
nyl-1H-pyrazole (4s). Colorless needles; yield 368 mg (80%); mp
109 °C (EtOH−Me CO−H O); H NMR (400 MHz, DMSO-d ): δ
2
2
6
1
1
38−139 °C (EtOH−Me CO−H O); H NMR (400 MHz, CDCl ):
10.06 (s, 1H), 7.85−7.80 (m, 2H), 7.72−7.71 (m, 1H), 7.53−7.48
(m, 3H), 7.35−7.26 (m, 4H), 6.95−6.86 (m, 3H), 6.68 (d, J = 3.3 Hz,
2
2
3
δ 7.58−7.53 (m, 4H), 7.51−7.46 (m, 1H), 6.85 (s, 1H), 6.83−6.74
1
3
1
13
1
(
m, 3H), 6.42 (d, J = 3.4 Hz, 1H), 6.37−6.35 (m, 2H); C{ H}
1H), 6.57−6.56 (m, 1H); C{ H} NMR (101 MHz, DMSO-d ): δ
6
NMR (101 MHz, CDCl ): δ 154.0, 150.4, 143.7, 142.0, 139.0, 129.4,
152.7, 144.3, 143.8 (CH), 132.7 (CH), 130.2 (CH), 129.5 (CH),
129.1 (CH), 126.5, 125.6 (CH), 121.7, 121.2 (CH), 118.9 (CH),
3
1
1
28.5, 125.7, 123.0, 121.5, 119.1, 113.7, 113.6, 113.2, 112.6, 108.6,
00.7; IR (CHCl , cm ) ν 1593, 1495, 1481, 1458; Anal. Calcd for
−
1
3
114.3 (CH), 112.7 (CH), 110.4 (CH), 103.1, 78.6; IR (CHCl ,
3
−
1
C H Br N O : C, 49.60; H, 2.63; Br, 34.73. Found: C, 49.80; H,
cm ) ν 3308 (NH), 2189 (CC), 1601 (CN); Anal. Calcd for
1
9
12
2
2
2
−
4
2
3
.88; Br, 34.41; UV−vis λ (ε × 10 ) 327 (3.58) nm; emission λ
93 nm.
C H N O: C, 80.75; H, 5.16. Found: C, 80.69; H, 5.36.
21 16
max
max
2
1-((E)-1-(5-Methylfuran-2-yl)-5-phenylpent-1-en-4-yn-3-yli-
5
-((1E,3E)-4-(Furan-2-yl)buta-1,3-dien-1-yl)-1,3-diphenyl-1H-
dene)-2-phenylhydrazine (6b). Orange needles; yield 222 mg (68%);
1
pyrazole (4t). Orange needles; yield 277 mg (82%); mp 141−142 °C
mp 112−113 °C (EtOH−Me CO−H O); H NMR (400 MHz,
2
2
1
(
EtOH−H O); H NMR (400 MHz, DMSO-d ): δ 7.91−7.88 (m,
DMSO-d ): δ 10.00 (s, 1H), 7.84−7.80 (m, 2H), 7.53−7.49 (m, 3H),
2
6
6
2
7
6
H), 7.671−7.668 (m, 1H), 7.62−7.49 (m, 5H), 7.47−7.44 (m, 2H),
7.35−7.26 (m, 4H), 6.90−7.84 (m, 2H), 6.80 (d, J = 15.9 Hz, 1H),
1
3
1
.38−7.34 (m, 1H), 7.31 (s, 1H), 7.11 (dd, J = 15.5, 10.9 Hz, 1H),
6.54 (d, J = 3.1 Hz, 1H), 6.18−6.17 (m, 1H), 2.33 (s, 3H); C{ H}
.83 (dd, J = 15.5, 10.9 Hz, 1H), 6.65 (d, J = 15.5 Hz, 1H), 6.58−6.53
NMR (101 MHz, DMSO-d ): δ 152.9, 151.3, 144.4, 132.6 (CH),
6
1
(
m, 3H); 13C{ H} NMR (101 MHz, DMSO-d ): δ 152.9, 151.5,
130.2 (CH), 129.5 (CH), 129.1 (CH), 126.7, 124.2 (CH), 121.7,
6
1
1
1
43.9, 143.0, 139.5, 133.2, 133.1, 129.9, 129.22, 128.6, 128.5, 127.4,
25.81, 125.80, 122.3, 119.0, 112.7, 110.3, 101.8; IR (CHCl , cm ) ν
599, 1537, 1501, 1479, 1358; Anal. Calcd for C H N O: C, 81.63;
H, 5.36. Found: C, 81.49; H, 5.62; HRMS (ESI) m/z calcd for
121.0 (CH), 119.0 (CH), 114.2 (CH), 111.8 (CH), 109.1 (CH),
−
1
−1
3
102.9, 78.6, 14.0 (CH); IR (CHCl , cm ) ν 3310 (NH), 2187 (C
3
2
3
18
2
C), 1601 (CN); Anal. Calcd for C H N O: C, 80.96; H, 5.56.
22 18
2
Found: C, 81.01; H, 5.36.
+
C H N O [M + H] 339.1497, found 339.1486.
1-((E)-1-(5-Nitrofuran-2-yl)-5-phenylpent-1-en-4-yn-3-ylidene)-
2
3
2
19
2
-(5-((1E,3E)-4-(Furan-2-yl)buta-1,3-dien-1-yl)-3-phenyl-1H-pyr-
2-phenylhydrazine (6c). Red powder; yield 311 mg (87%); mp 141−
1
azol-1-yl)pyridine (4u). Yellow needles; yield 255 mg (75%); mp
142 °C (EtOH−Me CO−H O); H NMR (400 MHz, DMSO-d ): δ
2
2
6
1
1
8
7
33−134 °C (EtOH−H O); H NMR (400 MHz, DMSO-d ): δ
10.46 (s, 1H), 7.86−7.81 (m, 2H), 7.77 (d, J = 4.0 Hz, 1H), 7.54−
7.50 (m, 3H), 7.42−7.40 (m, 2H), 7.34−7.25 (m, 3H), 7.09 (d, J =
2
6
.59−8.58 (m, 1H), 8.08−8.03 (m, 1H), 7.96−7.93 (m, 3H), 7.699−
.696 (m, 1H), 7.55 (d, J = 15.6 Hz, 1H), 7.51−7.37 (m, 5H), 7.14
1
3
1
4
.0 Hz, 1H), 6.98−6.94 (m, 2H); C{ H} NMR (101 MHz, DMSO-
(
dd, J = 15.6, 11.0 Hz, 1H), 6.87 (dd, J = 15.4, 11.0 Hz, 1H), 6.67 (d,
d ): δ 156.4, 151.4, 143.8, 133.0 (CH), 132.7 (CH), 130.3 (CH),
6
J = 15.4 Hz, 1H), 6.61 (d, J = 3.3 Hz, 1H), 6.56−6.55 (m, 1H);
C{ H} NMR (101 MHz, DMSO-d ): δ 153.2, 153.0, 151.9, 148.4,
44.0, 143.9, 139.8, 132.9, 132.7, 129.3, 128.9, 127.6, 126.0, 122.8,
22.1, 121.4, 117.4, 112.7, 110.4, 103.4; IR (CHCl , cm ) ν 1599,
537, 1501, 1458; Anal. Calcd for C H N O: C, 77.44; H, 5.21.
Found: C, 77.68; H, 5.33.
1
29.6 (CH), 129.1 (CH), 125.4, 122.1 (CH), 121.6, 116.4 (CH),
13
1
6
116.0 (CH), 114.9 (CH), 112.9 (CH), 103.7, 78.0; IR (CHCl ,
3
−
1
1
1
1
cm ) ν 3365 (NH), 1597 (CN); Anal. Calcd for C H N O : C,
2
1
15
3
3
−
1
3
70.58; H, 4.23. Found: C, 70.63; H, 4.34.
2
2
17
3
1-((E)-1-(Benzofuran-2-yl)-5-phenylpent-1-en-4-yn-3-ylidene)-2-
phenylhydrazine (6d). Yellow needles; yield 330 mg (91%); mp
1
5
-((1E,3E,5E)-6-(Furan-2-yl)hexa-1,3,5-trien-1-yl)-1,3-diphenyl-
148−149 °C (EtOH−Me CO−H O); H NMR (400 MHz, DMSO-
6
2
2
1
°
H-pyrazole (4v). Orange needles; yield 255 mg (81%); mp 129−130
d ): δ 10.24 (s, 1H), 7.88−7.84 (m, 2H), 7.63 (d, J = 7.4 Hz, 1H),
1
C (EtOH−Me CO−H O); H NMR (400 MHz, DMSO-d ): δ
7.58 (d, J = 8.1 Hz, 1H), 7.55−7.51 (m, 3H), 7.41−7.38 (m, 2H),
7.34−7.29 (m, 3H), 7.26−7.22 (m, 1H), 7.18 (d, J = 15.9 Hz, 1H),
2
2
6
7
7
1
6
1
1
1
.91−7.88 (m, 2H), 7.671−7.668 (m, 1H), 7.62−7.49 (m, 5H),
.47−7.43 (m, 2H), 7.38−7.34 (m, 1H), 7.32 (s, 1H), 7.10−7.04 (m,
H), 6.76−6.70 (m, 1H), 6.63−6.56 (m, 3H), 6.54−6.51 (m, 2H),
1
3
1
7.09−7.05 (m, 2H), 6.95−6.90 (m, 1H); C{ H} NMR (101 MHz,
DMSO-d ): δ 154.9, 154.8, 144.1, 132.70 (CH), 130.3 (CH), 129.5
6
1
3
1
.45 (d, J = 15.4 Hz, 1H); C{ H} NMR (101 MHz, DMSO-d ): δ
(CH), 129.3, 129.2 (CH), 129.0 (CH), 126.0, 125.43 (CH), 123.6
6
53.1, 151.5, 143.8, 143.0, 139.5, 135.3, 133.47, 133.40, 133.2, 129.9,
29.2, 128.6, 128.5, 127.4, 125.87, 125.80, 121.5, 118.6, 112.8, 110.3,
01.6; IR (CHCl , cm ) ν 1598, 1537, 1500, 1458; Anal. Calcd for
(CH), 121.7, 121.57 (CH), 121.53 (CH), 118.3 (CH), 114.5 (CH),
−
1
111.3 (CH), 106.5 (CH), 103.33, 78.50; IR (CHCl , cm ) ν 3321
3
−
1
3
(NH), 2187 (CC), 1603 (CN); Anal. Calcd for C H N O: C,
25 18
2
C H N O: C, 82.39; H, 5.53. Found: C, 82.40; H, 5.62.
82.85; H, 5.01. Found: C, 82.59; H, 5.29.
2
5
5
20
2
-(Furan-2-yl)-1-phenyl-3-((trimethylsilyl)ethynyl)-4,5-dihydro-
1-Phenyl-2-((E)-5-phenyl-1-(thiophen-2-yl)pent-1-en-4-yn-3-
1
H-pyrazole (3a). A solution of enynone 1n (218 mg, 1 mmol) and
ylidene)hydrazine (6e). Orange needles; yield 279 mg (85%); mp
1
phenylhydrazine 2a (119 mg, 1.1 mmol) in EtOH (2 mL) was
refluxed for 10 h. After the solution was cooled, the crystalline
precipitate was filtered off, washed with a minimal amount of cold
1
41−143 °C (with decomposition) (EtOH−Me CO−H O);
H
2
2
NMR (400 MHz, CDCl ): δ 8.69 (s, 1H), 7.69−7.65 (m, 2H), 7.52−
3
7
3
.45 (m, 3H), 7.36−7.32 (m, 2H), 7.26−7.19 (m, 4H), 7.12 (d, J =
13 1
EtOH, and dried in air. Light gray needles; yield 142 mg (46%); mp
.6 Hz, 1H), 7.05−7.03 (m, 1H), 6.99−6.93 (m, 2H); C{ H} NMR
1
1
28−129 °C (with decomposition) (EtOH−H O); H NMR (400
2
(101 MHz, CDCl ): δ 143.2, 142.4, 132.0, 129.7, 129.40, 129.40,
3
MHz, DMSO-d ): δ 7.574−7.567 (m, 1H), 7.21−7.16 (m, 2H),
6
128.7, 127.8, 127.4, 126.4, 125.0, 124.6, 121.4, 121.2, 113.5, 103.5,
−
1
7
6
1
.07−7.04 (m, 2H), 6.82−6.78 (m, 1H), 6.42 (d, J = 3.0 Hz, 1H),
7
7.5; IR (CHCl , cm ) ν 3308 (NH), 2187 (CC), 1603 (CN);
3
.38−6.36 (m, 1H), 5.64 (dd, J = 12.5, 5.6 Hz, 1H), 3.53 (dd, J =
Anal. Calcd for C H N S: C, 76.80; H, 4.91; S, 9.76. Found: C,
2
1
16
2
7.4, 12.5 Hz, 1H), 2.99 (dd, J = 17.4, 5.6 Hz, 1H), 0.24 (s, 9H);
7
7.11; H, 5.22; S, 9.59.
1-Phenyl-2-((E)-5-phenyl-1-(thiophen-3-yl)pent-1-en-4-yn-3-
13
1
C{ H} NMR (101 MHz, DMSO-d ): δ 152.6, 143.5, 143.4, 131.7,
29.4, 120.4, 114.2, 110.8, 108.7, 101.0, 99.0, 56.9, 42.1, 0.1; Anal.
6
1
ylidene)hydrazine (6f). Orange needles; yield 269 mg (82%); mp
7
238
J. Org. Chem. 2021, 86, 7229−7241